Search research articles
Contact Us
Filters
Showing results (131-140 of 367) with videos related to
Page
of 37
Sort By:
Acta Oncologica (Stockholm, Sweden)
|
August 24, 2017
Quality assessment of positron emission tomography scans: recommendations for future multicentre trials
Evelyn E C de Jong, Wouter van Elmpt, Otto S Hoekstra, et al.
Personalized Medicine
|
May 15, 2018
Detecting resistance in EGFR-mutated non-small-cell lung cancer after clonal selection through targeted therapy
Justine L Kuiper, Idris Bahce, Charlotte Voorhoeve, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 6, 2016
Quantitative and Simplified Analysis of 11C-Erlotinib Studies
Maqsood Yaqub, Idris Bahce, Charlotte Voorhoeve, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 22, 2021
Effects of Tracer Uptake Time in Non-Small Cell Lung Cancer <sup>18</sup>F-FDG PET Radiomics
Guilherme D Kolinger, David Vállez García, Gerbrand Maria Kramer, et al.
European Radiology
|
July 14, 2010
Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment?
Joline S W Lind, Martijn R Meijerink, Anne-Marie C Dingemans, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 12, 2016
International Experts Panel Meeting of the Italian Association of Thoracic Oncology on Antiangiogenetic Drugs for Non-Small Cell Lung Cancer: Realities and Hopes
Filippo de Marinis, Emilio Bria, Fortunato Ciardiello, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 23, 2003
European organization for research and treatment of cancer (EORTC) 08957 phase II study of topotecan in combination with cisplatin as second-line treatment of refractory and sensitive small cell lung cancer
Andrea Ardizzoni, Christian Manegold, Channa Debruyne, et al.
Respiratory Research
|
October 3, 2008
Membrane diffusion- and capillary blood volume measurements are not useful as screening tools for pulmonary arterial hypertension in systemic sclerosis: a case control study
Maria J Overbeek, Herman Groepenhoff, Alexandre E Voskuyl, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 15, 2012
Pharmacogenetic study of patients with advanced non-small cell lung cancer (NSCLC) treated with second-line pemetrexed or pemetrexed-carboplatin
Marcello Tiseo, Elisa Giovannetti, Carmelo Tibaldi, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 10, 2012
Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin
Martin Reck, Nick Thatcher, Egbert F Smit, et al.
Page
of 37
Search research articles
Search
Showing results (131-140 of 367) with videos related to
Sort By:
Page
of 37
Acta Oncologica (Stockholm, Sweden)
|
August 24, 2017
Quality assessment of positron emission tomography scans: recommendations for future multicentre trials
Evelyn E C de Jong, Wouter van Elmpt, Otto S Hoekstra, et al.
Personalized Medicine
|
May 15, 2018
Detecting resistance in EGFR-mutated non-small-cell lung cancer after clonal selection through targeted therapy
Justine L Kuiper, Idris Bahce, Charlotte Voorhoeve, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 6, 2016
Quantitative and Simplified Analysis of 11C-Erlotinib Studies
Maqsood Yaqub, Idris Bahce, Charlotte Voorhoeve, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 22, 2021
Effects of Tracer Uptake Time in Non-Small Cell Lung Cancer <sup>18</sup>F-FDG PET Radiomics
Guilherme D Kolinger, David Vállez García, Gerbrand Maria Kramer, et al.
European Radiology
|
July 14, 2010
Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment?
Joline S W Lind, Martijn R Meijerink, Anne-Marie C Dingemans, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 12, 2016
International Experts Panel Meeting of the Italian Association of Thoracic Oncology on Antiangiogenetic Drugs for Non-Small Cell Lung Cancer: Realities and Hopes
Filippo de Marinis, Emilio Bria, Fortunato Ciardiello, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 23, 2003
European organization for research and treatment of cancer (EORTC) 08957 phase II study of topotecan in combination with cisplatin as second-line treatment of refractory and sensitive small cell lung cancer
Andrea Ardizzoni, Christian Manegold, Channa Debruyne, et al.
Respiratory Research
|
October 3, 2008
Membrane diffusion- and capillary blood volume measurements are not useful as screening tools for pulmonary arterial hypertension in systemic sclerosis: a case control study
Maria J Overbeek, Herman Groepenhoff, Alexandre E Voskuyl, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 15, 2012
Pharmacogenetic study of patients with advanced non-small cell lung cancer (NSCLC) treated with second-line pemetrexed or pemetrexed-carboplatin
Marcello Tiseo, Elisa Giovannetti, Carmelo Tibaldi, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 10, 2012
Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin
Martin Reck, Nick Thatcher, Egbert F Smit, et al.
Page
of 37